节点文献

利用丙型肝炎病毒复制子模型检测重组人λ2干扰素的体外活性

Detection of Interferon λ2 Activity In Vitro by HCV Replicon Model

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张辉李亚东毕研伟宫悦李智华丁晨寸韡

【Author】 ZHANG Hui;LI Ya-Dong;BI Yan-Wei;GONG Yue;LI Zhi-Hua;DING Chen;CUN Wei;Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College;Yunnan Key Laboratory of Vaccine Research and Development of Severe Infectious Disease;

【机构】 中国医学科学院&北京协和医学院医学生物学研究所云南省重大传染病疫苗研发重点实验室

【摘要】 目的:利用丙型肝炎病毒(HCV)复制子细胞模型,体外研究重组人λ2干扰素(hIFNλ2)对HCV复制子的抑制作用。方法:构建重组质粒pcDNA3.1-hIFNλ2-HA,转染293T细胞,表达带有HA标签的hIFNλ2,表达后的上清通过Western印迹检测,然后稀释至不同浓度后作用于带有HCV复制子的Huh7.5细胞系,每隔24h取样并更换培养液,通过报告基因检测hIFNλ2对HCV复制子的抑制作用。结果:构建了pcDNA3.1-hIFNλ2-HA真核表达重组体,并在293T细胞中表达出hIFNλ2,该蛋白能有效抑制HCV复制子的复制。结论:hIFNλ2对HCV复制子具有抑制作用。

【Abstract】 Objective: To study the inhibitory effect of recombinant human interferon λ2(hIFNλ2) on HCV replicon in vitro by using cell culture system of HCV replicon. Methods: This study constructed recombinant plasmid pcDNA3.1-hIFNλ2-HA, and expressed the hIFNλ2 with HA tag in 293 T cells, then detected the supernatant of the cell by Western blot, and then used supernatant diluted with different ratio to effect on Huh7.5 cell culture system with HCV replicon, samples were collected every 24 hours and replaced the medium, finally using the report gene to detect the inhibitory effect of the hIFNλ2 in HCV virus replicon. Results: The eukaryotic expression recombinant plasmid pcDNA3.1-hIFNλ2 was successfully contructed, and hIFNλ2 was expressed in 293 T cells,and confirmed that the hIFNλ2 could inhibit the replication of HCV. Conclusion: The results proved that hIFNλ2 has a direct inhibitory effect on HCV replicon.

【基金】 云南省重点新产品开发计划(2015BC010)
  • 【文献出处】 生物技术通讯 ,Letters in Biotechnology , 编辑部邮箱 ,2017年05期
  • 【分类号】R373.21
  • 【被引频次】1
  • 【下载频次】64
节点文献中: 

本文链接的文献网络图示:

本文的引文网络